Steven Foster - Dec 31, 2023 Form 5 Insider Report for Tenon Medical, Inc. (TNON)

Role: CEO and President, Director
Signature: /s/ Steven Foster
Stock symbol: TNON
Transactions as of: Dec 31, 2023
Transactions value $: $5,518
Form type: 5
Date filed: 2/13/2024, 04:48 PM
Previous filing: May 24, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TNON	Common Stock	Conversion of derivative security	$7.32K	+3.62K	+60.33%	$2.02	9.63K	Nov 22, 2023	Direct	F1
transaction	TNON	Common Stock	Tax liability	-$1.8K	-901	-9.36%	$2.00	8.73K	Nov 27, 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	TNON	Restricted Stock Units						10.9K	Dec 31, 2023	Common Stock	10.9K		Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares of common stock were issued pursuant to the vesting of Restricted Stock Units.
F2	These shares were sold to pay tax liability associated with the vesting of Restricted Stock Units.
F3	Each Restricted Stock Unit represents the right to receive one share of Common Stock. These units are on a 3 year vesting schedule, for the first year they vest on an annual basis and thereafter they vest on a semi-annual basis. 21,746 (post-split) Restricted Stock Units were initially granted on May 12, 2022. 10,872 Restricted Stock Units vested as of December 31, 2023.